Reduced Expression of<i>CAMTA1</i>Correlates with Adverse Outcome in Neuroblastoma Patients
Kai-Oliver Henrich(German Cancer Research Center), Frank Westermann(German Cancer Research Center), Jun S. Wei(Center for Cancer Research), Frank Berthold(University of Cologne), Benedikt Brors(German Cancer Research Center), Javed Khan(Kent State University), Matthias Fischer(University of Cologne), Ruprecht Wiedemeyer(Broad Institute), Daniel Mertens(German Cancer Research Center), Manfred Schwab(German Cancer Research Center), André Oberthuer, Axel Benner(Memorial Sloan Kettering Cancer Center)
Cited by 64
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
|Nature Genetics|2020|790